included 181 GBM patients available of imaging information (CE-T1, FLAIR, and T2WI), DNA methylation profiling (MGMT methylation status and global DNA methylation pattern), treatment (surgery, TMZ chemotherapy and/or radiation), and patients’ individual information (62). The gene discussed is MGMT; the disease is glioblastoma.